China Cancer Drugs Market – Forecast by Drugs, Cancer & Therapy - PowerPoint PPT Presentation

About This Presentation
Title:

China Cancer Drugs Market – Forecast by Drugs, Cancer & Therapy

Description:

China Cancer Drug Market will surpass US$ 30.5 Billion by the year end of 2025. Renub Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market. Access full Research: – PowerPoint PPT presentation

Number of Views:105

less

Transcript and Presenter's Notes

Title: China Cancer Drugs Market – Forecast by Drugs, Cancer & Therapy


1
China Cancer Drugs Market
China Cancer Drugs Market
2
Report Description and Highlights
Cancer is one of the biggest burdens for so many
public health departments across the world and
China has even more cancer patients due to
growing population at rapid pace. According to
GLOBCAN, nearly 2.9 Million new cancer deaths
happened in China in the year 2018. If we talk
about cancer incidence, this rate is much lower
in China rather than United States and United
Kingdom. But when we talk about mortality rate,
China mortality rate is almost 30 to 40 higher
than the United States and United Kingdom.
Moreover, increasing diagnostic center, improving
cancer treatment therapy and acceptance of
targeted drug therapy will further boost the
China cancer market in forecast period. However,
expensive cancer drug and various side-effects
will also hinder the market. According to Renub
Research Analysis, China Cancer Drug Market will
surpass US 30.5 Billion by the year end of 2025.
China Cancer Drugs Market
3
China Cancer Drugs Market
China cancer drug market has grown rapidly in
historical period and it is expected to grow
significantly during the forecast period. There
are various factors that will help the market to
outperform rising ageing population in China,
changes of lifestyle and food habits, rising
incidence rate of several type of cancer, rise in
tobacco smoking population due to expansion of
urbanization in China, improving healthcare
infrastructure and facilities in China,
increasing per capita disposable income, rising
per capita healthcare expenditure, improving
awareness regarding cancer risk, potential due to
emerging economies etc.
China Cancer Drugs Market
4
China Cancer Drugs Market
Renub Research report titled China Cancer Drugs
Market, by Drugs Cytotoxic Drugs
(Antimetabolities, Plant Alkaloids, Alkylating
Agents), Targeted Drugs, Monoclonal Antibiotics,
Hormonal Drugs, Traditional Chinese Medicine
(TCM), Others, Cancer (Lung, Stomach, Breast,
Esophageal, Liver Others), Therapy
(Chemotherapy, Targeted Therapy, Hormonal Therapy
Others), Companies (Merck, Celgene, Eli Lilly,
Roche Sino BioPharma) provides a complete
analysis of China Anti-Cancer Drugs Market.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lchina-cancer-drugs-market-p.php
China Cancer Drugs Market
5
China Cancer Drugs Market
China Cancer Drug Market Insight by Drug Type In
this report, China cancer drugs market is
fragmented by drug type into six parts Targeted
Drugs, Cytotoxic Drugs, Monoclonal Antibiotics,
Hormonal Drugs, TCM and Others. Cytotoxic Drugs
type is further categorized into three parts
Antimetabolites, Plant Alkaloids and Alkylating
Agents. Currently targeted drugs have more
ability to kill malignant cells and it is quite
popular because of higher success rate and
efficacy. China Cancer Drug Market Insight by
Types of Cancer In this report, we have done
in-depth analysis of market by types of cancer
Lung, Stomach, Breast, Esophageal, Liver
Others China Cancer Drug Market Insight by
Therapy According Renub Research, targeted drug
therapy is growing significantly in China due its
higher efficacy and success rate than other
therapy. In this report, we have design
multi-dimensional approach to study all the
cancer therapy which includes various important
variables such as prime factors that support
market growth, opportunities in each therapy,
challenges faced by particular therapy etc.
China Cancer Drugs Market
6
China Cancer Drugs Market
By Cancer     Lung Cancer    Stomach
Cancer    Breast Cancer    Esophageal
Cancer    Liver Cancer    Others
By Drugs     Cytotoxic Drugs o  
 Antimetabolities o    Plant Alkaloids
o    Alkylating Agents     Targeted Drugs  
 Monoclonal Antibiotics    Hormonal Drugs  
 Traditional Chinese Medicine (TCM)    Others
China Cancer Drugs Market
7
China Cancer Drugs Market
By Therapy     Chemotherapy    Targeted
Therapy    Hormonal Therapy  
 Others Companies Covered in the Report   
 Merck    Celegene    Eli Lilly  
 Roche    Sino BioPharma
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlchina-cancer-drugs-market-p.php
China Cancer Drugs Market
8
China Cancer Drugs Market
Browse Related Report Epilepsy Drugs
Market Diabetes Drug Market Contact Us Tel
1-678-302-0700 (US), 91-120-421-9822
(INDIA) Email info_at_renub.com
China Cancer Drugs Market
Write a Comment
User Comments (0)
About PowerShow.com